http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2015119259-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-28
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2013-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2015119259-A
titleOfInvention IMPROVED METHOD FOR PRODUCING 5- (2,6-DI-4-MORPHOLINYL-4-PYRIMIDINYL) -4-TRIFTORMETHYLPYRIDIN-2-AMINE
abstract 1. A method for producing a compound of formula A, comprising the steps of: (a) acylating 5-bromo-4- (trifluoromethyl) pyridin-2-amine to form N- (5-bromo-4- (trifluoromethyl) pyridin-2-yl) acetamide; ( b) the interaction of N- (5-bromo-4- (trifluoromethyl) pyridin-2-yl) acetamide with a Grignard alkyl reagent, followed by the addition of trialkyl borate and 2,2'-azanediyl diethanol in an organic solvent to form N- (5- (1, 3,6,2-dioxazaborocan-2-yl) -4- (trifluoromethyl) pyridin-2-yl) acetamide; (c) a combination of N- (5- (1,3,6,2-dioxazaborocan-2-yl) -4- (trifluoromethyl) pyridin-2-yl) acetamide with 4.4 '- (6-chloropyrimidin-2,4-d iyl) di [morpholine] via the palladium-catalyzed Suzuki coupling reaction to form N- (5- (2,6-dimorpholinopyrimidin-4-yl) -4- (trifluoromethyl) pyridin-2-yl) acetamide; and (d) hydrolyzing N- (5- (2,6-dimorpholinopyrimidin-4-yl) -4- (trifluoromethyl) pyridin-2-yl) acetamide under an acidic medium to form a compound of formula A.2. The method of claim 1, wherein the Grignard alkyl reagent of step (b) is lithium isopropyl magnesium chloride in tetrahydrofuran and the trialkyl borate is triisopropyl borate. 3. The method of claim 2, wherein the palladium-catalyzed Suzuki combination of step (c) comprises generating a palladium catalyst in situ from palladium acetate and triphenylphosphine in an organic solvent. The method of claim 3, wherein the hydrolyzed N- (5- (2,6-dimorpholinopyrimidin-4-yl) -4- (trifluoromethyl) pyridin-2-yl) acetamide is treated with N-acetyl-L-cysteine. A compound that is N- (5- (1,3,6,2-dioxazaborocan-2-yl) -4- (trifluoromethyl) pyridin-2-yl) acetamide. 6. A compound that is N- (5- (1,3,6,2-dioxazaborocan-2-yl) -4- (trifluoromethyl) pyridin-2-yl) amine. 7. A process for preparing a compound of formula A, comprising the steps of: (a) reacting 5-bromo-4- (trifluoromethyl) pyridin-2-amine with an alkyl reagent
priorityDate 2012-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66833835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416059888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424670844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74222646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15220664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450422860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413195982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454250970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15182658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87138806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428552833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415708992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28875348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413224394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16654980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453130162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426265688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450461534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449783336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76286470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448924032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID433294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID686334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158163356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449806164

Total number of triples: 66.